MX2015013307A - Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica. - Google Patents

Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica.

Info

Publication number
MX2015013307A
MX2015013307A MX2015013307A MX2015013307A MX2015013307A MX 2015013307 A MX2015013307 A MX 2015013307A MX 2015013307 A MX2015013307 A MX 2015013307A MX 2015013307 A MX2015013307 A MX 2015013307A MX 2015013307 A MX2015013307 A MX 2015013307A
Authority
MX
Mexico
Prior art keywords
vaccine
ruminant
protect
mannheimia haemolytica
pneumonia caused
Prior art date
Application number
MX2015013307A
Other languages
English (en)
Other versions
MX357432B (es
Inventor
Antonius Arnoldus Christiaan Jacobs
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47900898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015013307(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2015013307A publication Critical patent/MX2015013307A/es
Publication of MX357432B publication Critical patent/MX357432B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una vacuna para su administración en el tracto respiratorio superior de un rumiante, para proteger a dicho rumiante contra la neumonía causada por Mannheimia haemolytica, la vacuna comprende, en combinación, la bacteria atenuada viva Mannheimia haemolytica, el virus atenuado vivo de parainfluenza-3 y el virus respiratorio sincicial bovino atenuado vivo, en donde la vacuna es para su administración en el tracto respiratorio superior del rumiante, por medio de la atomización intranasal de la vacuna.
MX2015013307A 2013-03-18 2014-03-17 Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica. MX357432B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13159665 2013-03-18
PCT/EP2014/055244 WO2014147001A1 (en) 2013-03-18 2014-03-17 Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica

Publications (2)

Publication Number Publication Date
MX2015013307A true MX2015013307A (es) 2016-01-25
MX357432B MX357432B (es) 2018-07-09

Family

ID=47900898

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013307A MX357432B (es) 2013-03-18 2014-03-17 Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica.

Country Status (9)

Country Link
US (1) US9642905B2 (es)
EP (1) EP2976102B1 (es)
AU (1) AU2014234452B2 (es)
BR (1) BR112015023870A2 (es)
ES (1) ES2771473T3 (es)
HU (1) HUE048344T2 (es)
MX (1) MX357432B (es)
PL (1) PL2976102T3 (es)
WO (1) WO2014147001A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
EP2976102B1 (en) 2013-03-18 2019-12-11 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
CN115161211B (zh) * 2021-04-01 2023-07-14 金宇保灵生物药品有限公司 一种牛溶血性曼氏杆菌菌株及由其制备的灭活疫苗和疫苗制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132775A (en) * 1973-12-03 1979-01-02 Richardson-Merrell Inc. Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same
US5256415A (en) 1989-03-20 1993-10-26 Louisiana State University Vaccine against bovine respiratory disease (pasteurellosis)
EP0650734B1 (en) 1993-10-28 1999-03-10 Division Of Microbiology, Kyoto Biken Laboratories, Inc. Pentavalent live viral vaccine
EP0810283A3 (en) * 1996-05-31 1997-12-10 Akzo Nobel N.V. Live attenuated RTX-procucing bacteria of the family Pasteurellaceae
FI20002217A (fi) 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalaatiopartikkelit
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
MXPA05002255A (es) 2002-08-26 2005-06-08 Pfizer Prod Inc Vacunas para infecciones del sistema respiratorio y reproductor en ganado.
US6830010B2 (en) 2002-10-22 2004-12-14 Heartland Premium Beef, Inc. Quality assurance program and method for meat production
WO2004064776A2 (en) 2003-01-14 2004-08-05 Mississippi State University Methods of preparation of live attenuated bacterial vaccines by alteration of dna adenine methylase (dam) activity in those bacteria
BRPI0410911B1 (pt) 2003-07-02 2014-07-08 Biotechnology Res & Dev Mutantes acapsulares de p. multocida por deleção de hyae
FR2862306B1 (fr) 2003-11-17 2008-05-30 Aventis Pasteur Composition vaccinale
EP1725256A4 (en) * 2004-02-18 2008-12-31 Univ Newcastle Res Ass VACCINE FORMULATION FOR ADMINISTRATION TO THE LUNGSSCHLEIMHAUT
AU2005331860B2 (en) 2004-12-22 2011-08-11 Intervet International B.V. Pasteurella multocida vaccine
WO2008118902A1 (en) 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
EP2976102B1 (en) 2013-03-18 2019-12-11 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica

Also Published As

Publication number Publication date
EP2976102A1 (en) 2016-01-27
HUE048344T2 (hu) 2020-08-28
MX357432B (es) 2018-07-09
AU2014234452A1 (en) 2015-09-10
ES2771473T3 (es) 2020-07-06
US9642905B2 (en) 2017-05-09
PL2976102T3 (pl) 2020-05-18
WO2014147001A1 (en) 2014-09-25
EP2976102B1 (en) 2019-12-11
AU2014234452B2 (en) 2018-02-22
US20160287690A1 (en) 2016-10-06
BR112015023870A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
NZ704584A (en) Liquid stable virus vaccines
NZ630753A (en) Vaccine against rsv
SG10201801431TA (en) Respiratory syncytial virus (rsv) vaccine
IN2014DN09173A (es)
MX2015012737A (es) Vacunas de virus bovino liquidas estables.
HK1221653A1 (zh) 用於呼吸遞送三種或更多種活性劑的組合物、方法和系統
MX2017002803A (es) Coronavirus bovino atenuado y vacunas relacionadas.
IL240504A0 (en) Combined vaccine for respiratory syncytial virus and influenza
MX2015012397A (es) Composiciones y metodos basados en anticuerpos neutralizados suministrados intranasalmente para eficacia terapeutica aumentada.
HUE055409T2 (hu) Vakcinázási összeállítás vakcina jércemadarakhoz való továbbítására
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
GB2518813A (en) OMV vaccine against Burkholderia infections
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
HK1247140A1 (zh) 用於藥物有效地呼吸同步遞送到肺部的方法和系統
NZ725681A (en) Nebulization of immunoglobulin
GB201407318D0 (en) Couplings, tracheostomy Tubes and airways systems
HK1223644A1 (zh) 呼吸道合胞病毒半活疫苗
MX356560B (es) Vacuna para proteger a un rumiante contra la neumonia causada por pasteurella multocida.
MX2015013307A (es) Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica.
ZA201309028B (en) Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
PT3511015T (pt) Vacina viva e atenuada e geneticamente estável contra o vírus sincicial respiratório e a sua produção
BR212016024092U2 (pt) dispositivo a ser utilizado como técnica instrumental de re-expansão pulmonar
HK1223643A1 (zh) 呼吸道合胞病毒半活疫苗
WO2013166430A3 (en) Delivery of gaseous imaging contrast agent
EP3046578A4 (en) Recombinant respiratory syncytial virus (rsv) and vaccines

Legal Events

Date Code Title Description
FG Grant or registration